Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken ...

McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer ...

Voices of Oncology” by Kirk V. Shepard, M.D., and Ramin Farhood, PharmD, M.B.A., is released with Forbes Books.

BioNTech's Phase 3 breast cancer data supports its oncology shift, but global impact is limited and competition remains ...

German medtech company Siemens Healthineers is betting on early detection and digital tools as cancer cases rise.

A new study co-authored by Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer ...

Think of them as medical detectives, helping doctors detect issues at the genomic level before they become life-threatening ...

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers devoted to patient care, research, and ...

BioNTech, founded in 2008 in Germany, has become a key player in the development of personalized mRNA cancer treatments. The emerging biotech's first commercial vaccine, for covid, received its first ...

The African Medical Centre of Excellence (AMCE) has reaffirmed its commitment to tackling the growing cancer burden in ...

The centre offers a range of services, including preventive screenings, advanced diagnostics, surgical oncology, breast ...